Get the Stockscreener App
17.53
1.62%
0.0273
Neuphoria Therapeutics Inc stock is traded at $17.53, with a volume of 9,492.
It is up +1.62% in the last 24 hours and up +36.69% over the past month.
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators.
See More
Previous Close:
$17.50
Open:
$17.3
24h Volume:
9,492
Relative Volume:
0.15
Market Cap:
$33.43M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-11.08%
1M Performance:
+36.69%
6M Performance:
+259.27%
1Y Performance:
+0.00%
1-Day Range:
$17.30
$17.80
1-Week Range:
$17.07
$21.40
52-Week Range:
$2.90
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Name
Neuphoria Therapeutics Inc
Sector
Industry
Phone
781-439-5551
Address
100 SUMMIT DR, BURLINGTON
Compare NEUP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
17.78 | 41.26M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.61 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.50 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
548.58 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
797.69 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.54 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-28-23 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-28-23 | Reiterated | Maxim Group | Buy |
| Jan-10-22 | Initiated | Berenberg | Buy |
| Jan-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-10-22 | Initiated | Evercore ISI | Outperform |
| Jan-10-22 | Initiated | H.C. Wainwright | Buy |
View All
Neuphoria Therapeutics Inc Stock (NEUP) Latest News
Will Neuphoria Therapeutics Inc. stock keep outperforming rivalsPortfolio Update Report & Daily Profit Focused Stock Screening - newser.com
Using data models to predict Neuphoria Therapeutics Inc. stock movementMarket Sentiment Review & Comprehensive Market Scan Reports - newser.com
How sentiment analysis helps forecast Neuphoria Therapeutics Inc.Trade Entry Summary & High Yield Equity Trading Tips - newser.com
Predicting Neuphoria Therapeutics Inc. trend using moving averages2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
Neuphoria Therapeutics Inc. stock outlook for YEARPortfolio Update Report & Low Drawdown Investment Strategies - newser.com
Is Neuphoria Therapeutics Inc. stock cheap compared to fundamentals2025 Year in Review & Reliable Entry Point Trade Alerts - newser.com
Should you wait for a breakout in Neuphoria Therapeutics Inc.2025 Analyst Calls & Weekly Watchlist of Top Performers - newser.com
Ranking Neuphoria Therapeutics Inc. among high performing stocks via toolsWeekly Trade Summary & Verified Momentum Watchlists - newser.com
Can Neuphoria Therapeutics Inc. stock weather global recessionJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Comparing Neuphoria Therapeutics Inc. in custom built stock radarsJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
Will Neuphoria Therapeutics Inc. stock gain from government policies2025 Trading Volume Trends & Real-Time Volume Surge Alerts - newser.com
What machine learning models say about Neuphoria Therapeutics Inc.Quarterly Profit Summary & Verified Momentum Stock Alerts - newser.com
Measuring Neuphoria Therapeutics Inc.’s beta against major indicesJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
Will Neuphoria Therapeutics Inc. stock maintain momentum in 2025Trade Performance Summary & AI Enhanced Trading Alerts - newser.com
Neuphoria Therapeutics Inc. stock volume spike explainedTrade Risk Report & Free High Return Stock Watch Alerts - newser.com
What candlestick patterns are forming on Neuphoria Therapeutics Inc.July 2025 Closing Moves & Safe Swing Trade Setup Alerts - newser.com
Can volume confirm reversal in Neuphoria Therapeutics Inc.July 2025 Retail & Free Reliable Trade Execution Plans - newser.com
Published on: 2025-10-03 04:28:40 - newser.com
Published on: 2025-10-03 03:24:42 - newser.com
Published on: 2025-10-03 00:10:19 - newser.com
Reversal indicators forming on Neuphoria Therapeutics Inc. stockJuly 2025 Technicals & Fast Moving Stock Watchlists - newser.com
What drives Neuphoria Therapeutics Inc stock priceFibonacci Retracement Levels & Low Entry Investment Growth - earlytimes.in
Is Neuphoria Therapeutics Inc a good long term investmentPrice Momentum Alerts & Identify Breakout Stocks - earlytimes.in
Neuphoria completes patient visits in phase 3 social anxiety trial By Investing.com - Investing.com Nigeria
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates - GlobeNewswire
Neuphoria completes patient visits in phase 3 social anxiety trial - Investing.com India
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates - GlobeNewswire Inc.
Neuphoria Therapeutics Inc Stock (NEUP) Financials Data
There is no financial data for Neuphoria Therapeutics Inc (NEUP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.10%
2.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):